首页> 外文期刊>The journal of immunology >Induction of Telomerase Activity During Development of Human Mast Cells from Peripheral Blood CD34+ Cells: Comparisons with Tumor Mast-Cell Lines
【24h】

Induction of Telomerase Activity During Development of Human Mast Cells from Peripheral Blood CD34+ Cells: Comparisons with Tumor Mast-Cell Lines

机译:从外周血CD34 +细胞的人类肥大细胞发育过程中端粒酶活性的诱导:与肿瘤肥大细胞系的比较。

获取原文
           

摘要

To further characterize the development of mast cells from human hemopoietic pluripotent cells we have investigated the expression of telomerase activity in cultured human peripheral blood CD34+ cells, and CD34+/CD117+/CD13+ progenitor mast cells selected therefrom, with the idea that induction of telomerase is associated with clonal expansion of CD34+/CD117+/CD13+ cells. A rapid increase in telomerase activity preceded proliferation of both populations of cells in the presence of stem cell factor and either IL-3 or IL-6. The induction was transient, and telomerase activity declined to basal levels well before the appearance of mature mast cells. Studies with pharmacologic inhibitors suggested that this induction was initially dependent on the p38 mitogen-activated protein kinase and phosphatidylinositol 3′-kinase, but once cell replication was underway telomerase activity, but not cell replication, became resistant to the effects of inhibitors. Tumor mast cell lines, in contrast, expressed persistently high telomerase activity throughout the cell cycle, and this expression was unaffected by inhibitors of all known signaling pathways in mast cells even when cell proliferation was blocked for extended periods. These results suggest that the transient induction of telomerase activity in human progenitor mast cells was initially dependent on growth factor-mediated signals, whereas maintenance of high activity in tumor mast cell lines was not dependent on intracellular signals or cell replication.
机译:为了进一步表征来自人类造血多能细胞的肥大细胞的发育,我们研究了端粒酶活性在培养的人外周血CD34 +细胞和从中选择的CD34 + / CD117 + / CD13 +祖细胞中的表达,并认为与端粒酶的诱导相关CD34 + / CD117 + / CD13 +细胞的克隆扩增。在存在干细胞因子和IL-3或IL-6的情况下,端粒酶活性的快速增加先于两种细胞的增殖。诱导是短暂的,并且端粒酶活性在成熟肥大细胞出现之前就下降到基础水平。药理抑制剂的研究表明,这种诱导作用最初取决于p38丝裂原活化的蛋白激酶和磷脂酰肌醇3'-激酶,但是一旦细胞复制开始,端粒酶活性(而不是细胞复制)就会对抑制剂的作用产生抗性。相比之下,肿瘤肥大细胞系在整个细胞周期中均持续表达高端粒酶活性,即使肥大细胞被长时间阻滞,该表达不受肥大细胞中所有已知信号通路抑制剂的影响。这些结果表明,人类祖细胞肥大细胞中端粒酶活性的瞬时诱导起初取决于生长因子介导的信号,而肿瘤肥大细胞系中高活性的维持并不取决于细胞内信号或细胞复制。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号